TELA Bio Statistics

Total Valuation

TELA Bio has a market cap or net worth of $50.34 million. The enterprise value is $64.20 million.

Market Cap	50.34M
Enterprise Value	64.20M

Important Dates

The last earnings date was Thursday, November 13, 2025, after market close.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

TELA Bio has 43.77 million shares outstanding. The number of shares has increased by 78.98% in one year.

Current Share Class	43.77M
Shares Outstanding	43.77M
Shares Change (YoY)	+78.98%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	8.16%
Owned by Institutions (%)	32.10%
Float	20.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.66
Forward PS	0.56
PB Ratio	29.80
P/TBV Ratio	488.73
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	0.83
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.30, with a Debt / Equity ratio of 27.99.

Current Ratio	3.30
Quick Ratio	2.41
Debt / Equity	27.99
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-7.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-38.68%
Return on Invested Capital (ROIC)	-54.16%
Return on Capital Employed (ROCE)	-79.49%
Revenue Per Employee	$368,684
Profits Per Employee	-$186,593
Employee Count	209
Asset Turnover	1.34
Inventory Turnover	1.98

Taxes

Income Tax	-59,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -60.21% in the last 52 weeks. The beta is 0.87, so TELA Bio's price volatility has been lower than the market average.

Beta (5Y)	0.87
52-Week Price Change	-60.21%
50-Day Moving Average	1.32
200-Day Moving Average	1.57
Relative Strength Index (RSI)	44.85
Average Volume (20 Days)	351,775

Short Selling Information

The latest short interest is 416,541, so 0.95% of the outstanding shares have been sold short.

Short Interest	416,541
Short Previous Month	485,110
Short % of Shares Out	0.95%
Short % of Float	1.99%
Short Ratio (days to cover)	2.45

Income Statement

In the last 12 months, TELA Bio had revenue of $77.06 million and -$39.00 million in losses. Loss per share was -$0.89.

Revenue	77.06M
Gross Profit	52.19M
Operating Income	-35.46M
Pretax Income	-39.06M
Net Income	-39.00M
EBITDA	-34.41M
EBIT	-35.46M
Loss Per Share	-$0.89

Full Income Statement

Balance Sheet

The company has $29.71 million in cash and $43.57 million in debt, giving a net cash position of -$13.86 million or -$0.32 per share.

Cash & Cash Equivalents	29.71M
Total Debt	43.57M
Net Cash	-13.86M
Net Cash Per Share	-$0.32
Equity (Book Value)	1.56M
Book Value Per Share	0.04
Working Capital	39.07M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$30.88 million and capital expenditures -$621,000, giving a free cash flow of -$31.50 million.

Operating Cash Flow	-30.88M
Capital Expenditures	-621,000
Free Cash Flow	-31.50M
FCF Per Share	-$0.72

Full Cash Flow Statement

Margins

Gross margin is 67.73%, with operating and profit margins of -46.02% and -50.61%.

Gross Margin	67.73%
Operating Margin	-46.02%
Pretax Margin	-50.69%
Profit Margin	-50.61%
EBITDA Margin	-44.66%
EBIT Margin	-46.02%
FCF Margin	n/a

Dividends & Yields

TELA Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-78.98%
Shareholder Yield	-78.98%
Earnings Yield	-77.47%
FCF Yield	-62.58%

Analyst Forecast

The average price target for TELA Bio is $3.31, which is 187.83% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.31
Price Target Difference	187.83%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	16.79%
EPS Growth Forecast (5Y)	-52.72%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TELA Bio has an Altman Z-Score of -7.94 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-7.94
Piotroski F-Score	3